JP2021520408A - 経口ガム製剤およびその作製方法 - Google Patents

経口ガム製剤およびその作製方法 Download PDF

Info

Publication number
JP2021520408A
JP2021520408A JP2021503202A JP2021503202A JP2021520408A JP 2021520408 A JP2021520408 A JP 2021520408A JP 2021503202 A JP2021503202 A JP 2021503202A JP 2021503202 A JP2021503202 A JP 2021503202A JP 2021520408 A JP2021520408 A JP 2021520408A
Authority
JP
Japan
Prior art keywords
weight ratio
water
gelatin
sorbitol
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2021503202A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019192942A5 (https=
JP2021520408A5 (https=
Inventor
レジーヌ・デュタレ
オリヴィエ・ピャア
ローラン・スリペキ
ペルリーン・プーラントリュ
カトリーヌ・ブランディン
アイシャ・シェカル
エロディ・ラロエ
Original Assignee
サノフィ・ウィントロップ・インダストリエ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サノフィ・ウィントロップ・インダストリエ filed Critical サノフィ・ウィントロップ・インダストリエ
Publication of JP2021520408A publication Critical patent/JP2021520408A/ja
Publication of JPWO2019192942A5 publication Critical patent/JPWO2019192942A5/ja
Publication of JP2021520408A5 publication Critical patent/JP2021520408A5/ja
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2021503202A 2018-04-03 2019-03-29 経口ガム製剤およびその作製方法 Abandoned JP2021520408A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18305393.3 2018-04-03
EP18305393.3A EP3549579A1 (en) 2018-04-03 2018-04-03 Oral gum formulation and fabrication process thereof
PCT/EP2019/058109 WO2019192942A1 (en) 2018-04-03 2019-03-29 Oral gum formulation and fabrication process thereof

Publications (3)

Publication Number Publication Date
JP2021520408A true JP2021520408A (ja) 2021-08-19
JPWO2019192942A5 JPWO2019192942A5 (https=) 2022-03-18
JP2021520408A5 JP2021520408A5 (https=) 2022-03-18

Family

ID=61965891

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021503202A Abandoned JP2021520408A (ja) 2018-04-03 2019-03-29 経口ガム製剤およびその作製方法

Country Status (7)

Country Link
US (1) US20210093562A1 (https=)
EP (2) EP3549579A1 (https=)
JP (1) JP2021520408A (https=)
BR (1) BR112020019761A2 (https=)
MX (1) MX2020010400A (https=)
RU (1) RU2020135965A (https=)
WO (1) WO2019192942A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210307353A1 (en) * 2018-07-26 2021-10-07 Wm. Wrigley Jr. Company Process for reducing tempering time for deposited confectionery products
EP4255399A4 (en) * 2020-12-01 2024-12-18 Seattle Gummy Company Ped5 inhibitor semi-solid compositions and methods of making and using thereof
US20250066092A1 (en) * 2023-08-25 2025-02-27 Day Dreamers Confections Direct-Mold Blister Packaging System for Chocolate and Gummy Products

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897566A (en) * 1973-12-06 1975-07-29 Gen Foods Corp Chewing gums having longer lasting sweetness and flavor
US4780324A (en) * 1987-06-23 1988-10-25 Warner-Lambert Company Chewing gum with long lasting softness
US4804543A (en) * 1987-07-14 1989-02-14 Warner-Lambert Company Novel hydrophilic plasticizing system and chewing gum containing same
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
US6235318B1 (en) * 1999-01-21 2001-05-22 Charles M. Lombardy, Jr. Effervescent chewing gum
JP4783370B2 (ja) * 2004-08-25 2011-09-28 キャドバリー・アダムズ・ユーエスエイ・エルエルシー 液体充填チューインガム組成物
US20100136164A1 (en) * 2004-08-25 2010-06-03 Cadbury Adams Usa Llc Package assembly for multi-modality taste chewing gum compositions
JP2009159843A (ja) * 2007-12-28 2009-07-23 Uha Mikakuto Co Ltd チューインガムとその製造方法
CN101628117B (zh) * 2009-08-18 2011-02-16 北京航洋胶囊技术有限公司 一种咀嚼软胶囊皮、咀嚼软胶囊药物及其制备方法
JP6346623B2 (ja) 2013-02-14 2018-06-20 サノフイ 経口投与用の咀嚼可能な組成物およびその製造方法
CA2864531A1 (en) * 2014-02-06 2015-08-06 RAP Nutrition LLC High protein gummy product and process of making
US20160067180A1 (en) 2014-09-05 2016-03-10 Santa Cruz Pharmaceuticals, Inc. Semi-solid chewable dosage form for over-the-counter medications and method for producing same
ES2787220T3 (es) * 2015-03-26 2020-10-15 Patheon Softgels Inc Cápsulas blandas llenas de líquido
US9833408B1 (en) * 2016-07-28 2017-12-05 Allen Greenspoon Orally administrable formulation

Also Published As

Publication number Publication date
EP3549579A1 (en) 2019-10-09
WO2019192942A1 (en) 2019-10-10
MX2020010400A (es) 2021-02-09
EP3773470A1 (en) 2021-02-17
US20210093562A1 (en) 2021-04-01
RU2020135965A (ru) 2022-05-04
BR112020019761A2 (pt) 2021-01-26

Similar Documents

Publication Publication Date Title
US11872307B2 (en) Liquisoft capsules
CN101790372B (zh) 用于制备口腔崩解剂型的方法和组合物
Ubhe et al. A brief overview on tablet and it’s types
EP3154529B1 (en) Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
CN110944640A (zh) 果胶胶粘组合物及其制造和使用方法
JPWO2006070578A1 (ja) 硬カプセルのバンドシール
JP2021520408A (ja) 経口ガム製剤およびその作製方法
TWI622408B (zh) 用於口服之可嚼組合物及其製備方法
US20060165795A1 (en) Medicinal compositions comprising a core and a film based on modified cellulose derivatives
Ghorwade Formulation and evaluation of montelukast sodium fast dissolving films
US7780977B2 (en) Medication compositions
Conway Solid dosage forms
Hahm et al. Orally disintegrating tablets and related tablet formulations
Gupta et al. An overview of novel techniques employed in mouth dissolving drug delivery system
US20170209369A1 (en) Semi-solid chewable dosage form for over-the-counter medications and method for producing same
TW202410886A (zh) 凝膠皮膜及經口固形組成物
Shilpa Medicated chewing gum: a novel drug delivery system for the treatmnet of cough

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A525

Effective date: 20201120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220310

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220310

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20221125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20221125